Publications

Export 190 results:
Sort by: Author Title Type [ Year  (Desc)]
2012
Mabrouk, Mahasen, Gamal Esmat, Ayman Yosry, Magdy El-Serafy, Wahid Doss, Naglaa Zayed, Medhat El-Sahhar, Sally Awny, and Ashraf Omar. "Health-related quality of life in Egyptian patients after liver transplantation." ANNALS OF HEPATOLOGY 11 (2012): 882-890. Abstract
n/a
Khairy, Marwa, Mahassen Abdel-Rahman, Maissa El-Raziky, Wafaa El-Akel, Naglaa Zayed, Hany Khatab, and Gamal Esmat. "Non-Invasive Prediction of Hepatic Fibrosis in Patients With Chronic HCV Based on the Routine Pre-Treatment Workup." HEPATITIS MONTHLY 12 (2012). Abstract
n/a
Fathalla, Waleed, Wafaa El-Akel, Ahmad Salama, Gamal Esmat, and Mahasen Mabrouk. "The Effect of Peginterferon ALPHA-2A vs. Peginterferon alpha-2B in Treatment of NaiVE Chronic HCV Genotype-4 Patients: A Cohort Egyptian Study." GASTROENTEROLOGY 142 (2012): S939. Abstract
n/a
Mekky, Radwa Y., Nabila Hamdi, Wafaa El-Akel, Gamal Esmat, and Ahmed I. Abdelaziz. "Estrogen-related MxA transcriptional variation in hepatitis C virus-infected patients." TRANSLATIONAL RESEARCH 159 (2012): 190-196. Abstract
n/a
Esmat, Gamal, Mohamed Hashem, Mona El-Raziky, Wafaa El-Akel, Suzan El-Naghy, Nehal El-Koofy, Rokaya El-Sayed, Rasha Ahmed, Mohamed Atta-Allah, Mohamed Abdel Hamid et al. "Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children." LIVER INTERNATIONAL 32 (2012): 449-456. Abstract
n/a
Wiersma, S. T., B. McMahon, J. M. Pawlotsky, C. L. Thio, M. Thursz, S. G. Lim, P. Ocama, G. Esmat, M. Mendy, D. Bell et al. "Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus (vol 31, pg 755, 2011)." LIVER INTERNATIONAL 32 (2012): 174. Abstract
n/a
Esmat, G., M. El Raziky, M. El Kassas, M. Hassany, and M. E. Gamil. "The future for the treatment of genotype 4 chronic hepatitis C." LIVER INTERNATIONAL 32 (2012): 146-150. Abstract
n/a
El-Shamy, Ahmed, Ikuo Shoji, Wafaa El-Akel, Shymaa E. Bilasy, Lin Deng, Maissa El-Raziky, Da-peng Jiang, Gamal Esmat, and Hak Hotta. "NS5A Sequence Heterogeneity of Hepatitis C Virus Genotype 4a Predicts Clinical Outcome of Pegylated-Interferon-Ribavirin Therapy in Egyptian Patients." JOURNAL OF CLINICAL MICROBIOLOGY 50 (2012): 3886-3892. Abstract
n/a
Fawzy, I. O., M. Negm, R. Ahmed, G. Esmat, N. Hamdi, and A. I. Abdelaziz. "Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females." JOURNAL OF VIRAL HEPATITIS 19 (2012): 854-861. Abstract
n/a
Abbas, Emad, Olfat Shaker, Ghada Abd El Aziz, Huda Ramadan, and Gamal Esmat. "Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24 (2012): 458-463. Abstract
n/a
Elsharkawy, A., G. Esmat, M. El Raziky, W. Elakel, M. Abdel-Rahman, and M. Elsayed. "HCV/SCHISTOSOMIASIS COINFECTION: IMPACT ON FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN THERAPY." JOURNAL OF HEPATOLOGY 56 (2012): S61. Abstract
n/a
Yosry, Ayman, Mohamed Said, Gamal Esmat, Magdy Al-Serafy, Ashraf Omar, Wahid Doss, Dalia Omran, Yasmin Saad, Sanna Kamel, Akram Abdel-Bary et al. "HLA Tissue Typing Has No Effect on the Outcome of Patients Undergoing a Living-donor Liver Transplant: A Single-center Experience in Egypt." EXPERIMENTAL AND CLINICAL TRANSPLANTATION 10 (2012): 136-140. Abstract
n/a
El Tayebi, H. M., K. A. Hosny, G. Esmat, K. Breuhahn, and A. I. Abdelaziz. "MIR-155 IS AN INDUCER FOR THE INSULIN-LIKE GROWTH FACTOR II MITOGENIC SIGNALING PATHWAY IN HCV-PROGRESSED HEPATOCELLULAR CARCINOMA." JOURNAL OF HEPATOLOGY 56 (2012): S112. Abstract
n/a
ElHefnawi, Mahmoud, Mahmoud Abdalla, Safaa Ahmed, Wafaa elakel, Gamal Esmat, Maissa El Raziky, Shaima Khamis, and Marwa Hassan. "Accurate prediction of response to Interferon-based therapy in Egyptian patients with Chronic Hepatitis C using machine-learning approaches." In 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), 771-778., 2012. Abstract
n/a
Maher, Mohsen M., Sayed M. Shalaby, Gamal Esmat, Mohamed Abd El Adl Al-Sawey, Manal Zaghloul Maharan, Tarek M. Yosef, Wesam A. Ibrahim, Naglaa Zayed, Nesrine A. Mohamed, and Sarah Abdel Kader El-Nakeep. "Light Chain Antigenic Determinants (kappa and gamma) Influence on the Treatment Outcome of Chronic Hepatitis C Infection in Egypt." LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION 9 (2012): 2329-2333. Abstract
n/a
Hamdi, N., W. El-Akel, M. El-Serafy, G. Esmat, C. Sarrazin, and A. I. Abdelaziz. "Transcriptional Response of MxA, PKR and SOCS3 to Interferon-Based Therapy in HCV Genotype 4-Infected Patients and Contribution of p53 to Host Antiviral Response." INTERVIROLOGY 55 (2012): 210-218. Abstract
n/a
2011
Hatzakis, A., S. Wait, J. Bruix, M. Buti, M. Carballo, M. Cavaleri, M. Colombo, E. Delarocque-Astagneau, G. Dusheiko, G. Esmat et al. "The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference." JOURNAL OF VIRAL HEPATITIS 18 (2011): 1-16. Abstract
n/a
Hezode, Christophe, Gideon M. Hirschfield, Wayne Ghesquiere, William Sievert, Maribel Rodriguez-Torres, Stephen D. Shafran, Paul J. Thuluvath, Harvey A. Tatum, Imam Waked, Gamal E. Esmat et al. "BMS-790052, A NS5A REPLICATION COMPLEX INHIBITOR, COMBINED WITH PEGINTERFERON ALFA-2A AND RIBIVIRIN IN TREATMENT-NAIVE HCV-GENO-TYPE 1 OR 4 PATIENTS: PHASE 2B AI444010 STUDY INTERIM WEEK 12 RESULTS." HEPATOLOGY 54 (2011): 474A-475A. Abstract
n/a
Ashour, Mohamed K., Maissa E. Elraziky, Wafaa A. ElAkel, Amr Eldeeb, Mohamed Abdel-Hamid, Sherif El Kafrawy, Hani M. Khattab, and Gamal E. Esmat. "SAFETY, DOSAGE AND EFFICACY OF A NOVEL Y SHAPED MOLECULE OF PEGYLATED INTERFERON ALPHA 2A FOR TREATMENT OF CHRONIC HCV." HEPATOLOGY 54 (2011): 1006A. Abstract
n/a
Zakhari, Samir, Gamal Esmat, and Scott Friedman. "Introduction to the Symposium." ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 35 (2011): 775. Abstract
n/a
El Awady, Mostafa K., Mohamed A. Anany, Gamal Esmat, Naglaa Zayed, Ashraf A. Tabll, Amr Helmy, Abdel Rahman El Zayady, Mohga S. Abdalla, Hayat M. Sharada, Maissa El Raziky et al. "Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy." JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26 (2011): 843-850. Abstract
n/a
Hashem, Mohamed, Hanaa El-Karaksy, Mohamed T. Shata, Maha Sobhy, Heba Helmy, Suzan El-Naghi, Gehan Galal, Zainab Z. Ali, Gamal Esmat, Sayed F. Abdelwahab et al. "Strong Hepatitis C Virus (HCV)-specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children." JOURNAL OF INFECTIOUS DISEASES 203 (2011): 854-861. Abstract
n/a
El Tayebi, H. M., W. Salah, I. H. El Sayed, E. M. Salam, A. R. N. Zekri, N. Zayed, E. S. Salem, G. Esmat, and A. I. Abdelaziz. "Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients." BIOMARKERS 16 (2011): 346-354. Abstract
n/a
Elhawary, Eman I., Gamal F. Mahmoud, Mai A. El-Daly, Fatma A. Mekky, Gamal G. Esmat, and Mohamed Abdel-Hamid. "Association of HCV with diabetes mellitus: an Egyptian case-control study." VIROLOGY JOURNAL 8 (2011). Abstract
n/a
Tourism